|
TXLNG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.4023000255724E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.56290000519999E-08 |
| Normal-vs-Stage2 |
8.439000E-04 |
| Normal-vs-Stage3 |
7.66459995471536E-09 |
| Normal-vs-Stage4 |
2.52470000017269E-07 |
| Stage1-vs-Stage2 |
6.972200E-01 |
| Stage1-vs-Stage3 |
1.439770E-01 |
| Stage1-vs-Stage4 |
1.899580E-01 |
| Stage2-vs-Stage3 |
1.906180E-01 |
| Stage2-vs-Stage4 |
2.465600E-01 |
| Stage3-vs-Stage4 |
9.893000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.36909997070245E-09 |
| Normal-vs-AfricanAmerican |
8.537900E-03 |
| Normal-vs-Asian |
1.92153999999389E-05 |
| Caucasian-vs-AfricanAmerican |
3.342400E-01 |
| Caucasian-vs-Asian |
9.802800E-01 |
| AfricanAmerican-vs-Asian |
3.644600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.42035338624692E-12 |
| Normal-vs-Female |
1.43439999999995E-06 |
| Male-vs-Female |
8.70920002782327E-09 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.47970000047893E-07 |
| Normal-vs-Age(41-60Yrs) |
1.27950000039512E-07 |
| Normal-vs-Age(61-80Yrs) |
3.62580000468071E-08 |
| Normal-vs-Age(81-100Yrs) |
4.554300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.001200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.619800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.124230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.032000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.645440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.080000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.597600E-02 |
| Classical-VS-Follicular |
9.518100E-02 |
| Classical-VS-Other |
1.455750E-01 |
| Classical-VS-Normal |
2.86160000029234E-07 |
| Tall-VS-Follicular |
5.425800E-01 |
| Tall-VS-Other |
4.884400E-01 |
| Tall-VS-Normal |
3.46780000048952E-07 |
| Follicular-VS-Other |
4.299200E-01 |
| Follicular-VS-Normal |
5.2605000000483E-07 |
| Other-VS-Normal |
2.278200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.82400000448402E-08 |
| Normal-vs-N1 |
2.27320000001363E-06 |
| N0-vs-N1 |
6.298200E-01 |
|
|
